← Browse by Condition
Medical Condition
metastatic solid tumor
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for metastatic solid tumor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — metastatic solid tumor Clinical Trials
How many clinical trials are currently recruiting for metastatic solid tumor?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for metastatic solid tumor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for metastatic solid tumor?
metastatic solid tumor research spans Phase 1 (8 trials), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a metastatic solid tumor clinical trial?
Eligibility criteria for metastatic solid tumor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 8
Phase 2 4
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05856981 Phase 1
Recruiting
Enrollment
130 pts
Location
United States, Belgi...
Sponsor
Sairopa B.V.
NCT06975410 Phase 1, Phase 2
Recruiting
Enrollment
80 pts
Location
South Korea
Sponsor
Yuhan Corporation
NCT05694715 Phase 1
Recruiting
Enrollment
24 pts
Location
United States
Sponsor
University of California, San ...
NCT06590506
Recruiting
Enrollment
300 pts
Location
Spain
Sponsor
Centro Nacional de Investigaci...
NCT05875168 Phase 1, Phase 2
Recruiting
Enrollment
590 pts
Location
United States, Belgi...
Sponsor
Daiichi Sankyo
NCT07284186 Phase 1
Recruiting
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT07213830 Phase 1, Phase 2
Recruiting
Enrollment
102 pts
Location
United States, Canad...
Sponsor
Ipsen
NCT05118789 Phase 1, Phase 2
Recruiting
Enrollment
359 pts
Location
United States, Austr...
Sponsor
Nuvalent Inc.
NCT07156253 Phase 1
Recruiting
Enrollment
110 pts
Location
China
Sponsor
Hangzhou SynRx Therapeutics Bi...
Related Conditions
advanced solid tumor (3) locally advanced solid tumor (2) solid tumor adult (1) refractory cancer (1) crc colorectal cancer (1) rcc clear cell adenocarcinoma (1) nsclc advanced non small cell lung cancer (1) endometrial cancer (1) egfr overexpression (1) brca1 mutation (1) brca2 mutation (1) atm gene mutation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology